Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Consensus Rating of "Buy" by Analysts

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) have been assigned a consensus recommendation of "Buy" from the six brokerages that are presently covering the stock, MarketBeat reports. Four research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $12.13.

A number of brokerages have issued reports on BIOX. Oppenheimer reduced their price objective on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an "outperform" rating for the company in a research report on Monday, October 21st. Roth Mkm decreased their price target on Bioceres Crop Solutions from $15.00 to $13.00 and set a "buy" rating for the company in a research report on Wednesday, September 11th. Lake Street Capital dropped their price target on Bioceres Crop Solutions from $25.00 to $13.00 and set a "buy" rating on the stock in a report on Wednesday, September 11th. Finally, Canaccord Genuity Group reduced their price objective on Bioceres Crop Solutions from $10.00 to $9.50 and set a "buy" rating for the company in a research note on Wednesday, November 13th.

Institutional Trading of Bioceres Crop Solutions

Large investors have recently bought and sold shares of the company. Dimensional Fund Advisors LP grew its stake in shares of Bioceres Crop Solutions by 9.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company's stock worth $688,000 after acquiring an additional 5,341 shares during the period. Stifel Financial Corp lifted its holdings in Bioceres Crop Solutions by 33.4% during the third quarter. Stifel Financial Corp now owns 40,790 shares of the company's stock valued at $321,000 after purchasing an additional 10,224 shares during the last quarter. Ping Capital Management Inc. bought a new position in Bioceres Crop Solutions during the second quarter worth about $448,000. Sumitomo Mitsui Trust Holdings Inc. purchased a new position in shares of Bioceres Crop Solutions in the second quarter worth about $472,000. Finally, Long Focus Capital Management LLC increased its stake in shares of Bioceres Crop Solutions by 19.9% in the second quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company's stock worth $3,145,000 after purchasing an additional 46,647 shares in the last quarter. 17.68% of the stock is owned by hedge funds and other institutional investors.

Bioceres Crop Solutions Stock Up 1.6 %

Shares of BIOX traded up $0.10 on Friday, reaching $6.19. The company's stock had a trading volume of 100,873 shares, compared to its average volume of 102,001. Bioceres Crop Solutions has a twelve month low of $5.71 and a twelve month high of $14.05. The stock has a market capitalization of $389.03 million, a PE ratio of 309.65 and a beta of 0.51. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.37. The firm has a fifty day moving average of $6.78 and a 200-day moving average of $8.91.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last released its quarterly earnings results on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing analysts' consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The company had revenue of $92.60 million during the quarter, compared to analysts' expectations of $117.15 million. During the same period in the previous year, the company posted ($0.07) earnings per share. Equities analysts predict that Bioceres Crop Solutions will post 0.12 EPS for the current year.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.